Incidence and presentation of the central neurological manifestations of Wegener's granulomatosis: A monocentric study of 14 cases;Incidence et présentation des manifestations neurologiques centrales au cours de la granulomatose de Wegener: Analyse monocentrique d'une série de 14 malades

Revue de Medecine Interne

Volumn 25, Issue 3, 2004, Pages 183-188

  Konate A ^a   Le Falher, G ^a   Crozat Grosleron, S ^a   Riviere S ^a   Le Quellec, A ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

Central Nervous System; Cranial Nerves; Neurologic Manifestations; Vasculitis; Wegener's Granulomatosis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; METHOTREXATE; STEROID;

ADULT; AGED; APHASIA; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CRANIAL NEUROPATHY; DRUG EFFICACY; EYE DISEASE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; KIDNEY DISEASE; LUNG DISEASE; MALE; MENINGITIS; MOOD DISORDER; MUSCLE WEAKNESS; NEUROIMAGING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT; PERIPHERAL NEUROPATHY; RECURRENT DISEASE; REMISSION; RETROSPECTIVE STUDY; RHINOSINUSITIS; SENSIBILITY; SENSORY DYSFUNCTION; STEROID THERAPY; VASCULITIS; VEIN THROMBOSIS; WEGENER GRANULOMATOSIS;

EID: 1442277646     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(03)00266-2     Document Type: Article

References (27)

1. Cacoub P., Godeau P. Angéites cérébrales. Godeau P., Herson S., Piette J.C. Traité de médecine. 1996;656-660 Flammarion Médecine-Sciences, Paris.
2. Lê Thi Huong D., Papo T., Wechsler B., Piette J.C. Granulomatose de Wegener. Kahn M.F., Meyer O., Peltier A.P., Piette J.C. Maladies et syndromes systémiques. 2000;741-762 Flammarion Médecine-Sciences, Paris.
3. Nishino H., Rubino F.A., DeRemee R.A., Swanson J.W., Parisi J.E. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol. 33:1993;4-9.
4. Nishino H., Rubino F.A., Parisi J.E. The spectrum of neurologic involvement in Wegener's granulomatosis. Neurology. 43:1993;1334-1337.
5. Bajema I.M., Hagen E.C., Weverling-Rijnsburger A.W., van der Pijl H., van Dorp W.T., van Ravenswaay Claasen H.H., et al. Cerebral involvement in two patients with Wegener's granulomatosis. Clin Nephrol. 47:1997;401-406.
6. Wunscher W., Mobius G. Wegener's granulomatosis with involvement of the nervous system. Dtsch Z Nervenheilkd. 191:1967;158-174.
7. Fries J.F., Hunder G.G., Bloch D.A., Michel B.A., Arend W.P., Calabrese L.H., et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum. 33:1990;1135-1136.
8. Anderson G., Coles, Crane M., Douglas A.C., Gibbs A.R., Geddes D.M., et al. Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. Q J M. 83:1992;427-438.
9. Hoffman G.S., Kerr G.S., Leavitt R.Y., Hallahan C.W., Lebovics R.S., Travis W.D., et al. Wegener granulomatosis: An analysis of 158 patients. Ann Intern M. 116:1992;488-498.
10. Cordier J.F., Valeyre D., Guillevin L., Loire R., Brechot J.M. Pulmonary Wegener's granulomatosis. A clinical and imaging study of 77 cases. Chest. 97:1990;906-912.
11. Fauci A.S., Haynes B.F., Katz P., Wolff S.M. Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern M. 98:1983;76-85.
12. Pinching A.J., Lockwood C.M., Pussell B.A., Rees A.J., Sweny P., Evans D.J., et al. Wegener's granulomatosis: Observations on 18 patients with severe renal disease. Q J M. 52:1983;435-460.
13. Le Thi Huong D.U., Wechsler B., Cabane J., Piette J.C., Herreman G., Guillevin L., et al. Granulomatose de Wegener. Aspects cliniques, problèmes nosologiques. Revue de la littérature à propos de 30 observations. Ann Med Interne (Paris). 139:1988;169-182.
14. Drachman D.A. Neurological complications of Wegener's granulomatosis. Arch Neurol. 8:1963;45-55.
15. Anderson J.M., Jamieson D.G., Jefferson J.M. Non-healing granuloma and the nervous system. Q J M. 44:1975;309-323.
16. De Remee R., McDonald T.J., Harrison E.G. Jr, Coles D.T. Wegener's granulomatosis. Anatomic correlates, a proposed classification. Mayo Clin Proc. 51:1976;777-781.
17. Brandwein S., Esdaile J., Danoff D., Tannenbaum H. Wegener's granulomatosis. Clinical features and outcome in 13 patients. Arch Intern M. 143:1983;476-479.
18. Murphy J.M., Gomez-Anson B., Gillard J.H., Antoun N.M., Cross J., Elliott J.D., et al. Wegener granulomatosis: MR imaging findings in brain and meninges. Radiology. 213:1999;794-799.
19. Hurst R.W., Grossman R.I. Neuroradiology of central nervous system vasculitis. Semin Neurol. 14:1994;320-340.
20. Provenzale J.M., Allen N.B. Wegener granulomatosis: CT and MR findings. Am J Neuroradiol. 17:1996;785-792.
21. Asmus R., Koltze H., Muhle C., Spielmann R.P., Duncker G., Noelle B., et al. MRI of the head in Wegener's granulomatosis. Adv Exp Med Biol. 336:1993;319-321.
22. Walton E.W. Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis). Br Med J. 2:1958;265-270.
23. Specks U., Moder K.G., McDonald T.J. Meningeal involvement in Wegener granulomatosis. Mayo Clin Proc. 75:2000;856-859.
24. Reinhold-Keller E., de Groot K., Holl-Ulrich K., Arlt A.C., Heller M., Feller A.C., et al. Severe CNS manifestations as the clinical hallmark in generalized Wegener's granulomatosis consistently negative for antineutrophil cytoplasmic antibodies (ANCA). A report of 3 cases and a review of the literature. Clin Exp Rheumatol. 19:2001;541-549.
25. Albayram S., Kizilkilie O., Adaletli I., Erdogan N., Kocer N., Islak C. MR imaging findings of spinal dural involvement with Wegener granulomatosis. Am J Neuroradiol. 23:2002;1603-1606.
26. Mentzel H.J., Neumann T., Fitzek C., Sauner D., Reichenbach J.R., Kaiser W.A. MR imaging in Wegener granulomatosis of the spinal cord. Am J Neuroradiol. 24:2003;18-21.
27. Stumvoll M., Schnauder G., Overkamp D., Buettner U.W., Grodd W., Eggstein M. Systemic vasculitis positive for circulating anti-neutrophil antibodies and with predominantly neurological presentation. Clin Invest. 71:1993;613-615.